Israeli researchers on Monday said that they discovered a link between Pfizer’s COVID-19 vaccine and a rare blood disease called thrombotic thrombocytopenic purpura (TTP). Scientists with the Institute of Hematology at Shamir Medical Center said they began researching the possible link after reports of a sudden increase in TTP across Israel. The team said they discovered a “chronological connection” between when the Pfizer shot was administered to the patient and the onset of symptoms of the blood disease. They said that four cases were detected. “Physicians and patients need to be alert to the clinical symptoms: weakness fatigue, neurological disorders, hemorrhage and chest pain,” the Institute of Hematology at Shamir Medical Center told The Jerusalem Post. A spokesperson from the facility told the paper that the study is very small and should not deter individuals from getting the COVID-19 vaccine, and they added that Israelis who haven’t received the vaccine should still get inoculated. The researchers …